• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Masimo makes an offer in board election fight with Politan

Masimo makes an offer in board election fight with Politan

June 2, 2023 By Jim Hammerand

Masimo logoMasimo (Nasdaq: MASI) today promised to accept one of the board members proposed by Politan Capital Management under certain conditions while taking more shots at the activist investor’s leader.

The device developer said it would appoint former Johnson & Johnson MedTech executive Michelle Brennan to the board if shareholders voted to expand it from five members to seven.

Politan nominated Brennan along with Politan Managing Partner and Chief Investment Officer Quentin Koffey for two board seats up for election at the annual shareholder meeting this month.

Previously: Masimo beats the Street in Q1 ahead of proxy fight; CEO discusses Apple mistrial

Masimo asked shareholders to vote for their director nominees — incumbents H Michael Cohen and Julie Shimer — and to support a non-binding, advisory vote on the board’s expansion.

Shimer — chair of the Masimo Board Nominating Committee — accused Koffey of having “a history of misstatement and distortion and no relevant experience” in a news release.

Masimo said it would appoint Brennan to the board immediately after the June 26 annual meeting if shareholders support the board expansion and vote for both of Masimo’s nominees. Masimo has previously said it would select an external search firm to find new candidates for an expanded board.

This week, Masimo and Politan released dueling presentations supporting their respective campaigns. Both organizations have also launched websites: advancemasimo.com from Politan and keepmasimostrong.com from Masimo.

Politan responded on Monday with a statement from Koffey:

“Meaningful change is clearly needed on Masimo’s Board. For years, Masimo has gone to extreme and well-documented lengths to avoid this occurring. Making Michelle’s appointment contingent on all incumbent directors being elected is not progress – it is yet another defensive maneuver to impede shareholder-driven change,” he said in a news release.

“… Michelle wants to be able to bring the type of positive, substantive improvement to the Company that has been outlined in Politan’s campaign and will only be possible with a real level of change,” Koffey continued. “If elected, Michelle and I will be fully committed from day one to working constructively alongside the other directors to further the best interests of the Company. While we unfortunately expect the emotive attacks from Masimo to continue leading up to the vote, we encourage shareholders to look past these unproductive distractions.”

This post was originally published on June 2, 2023, and was updated with Politan’s response on June 5.

Filed Under: Blog, Business/Financial News, Featured, News Well, Patient Monitoring Tagged With: Masmio, Politan Capital Management

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

About Jim Hammerand

Jim Hammerand is the managing editor of Arrowfly's MassDevice and Medical Design & Outsourcing, where he leads coverage of medtech innovation, design, engineering and manufacturing. He also contributes to our Devicetalks podcasts and live events. Hammerand has more than two decades of journalism experience spanning newspapers, magazines, websites, live events, radio and TV news. For nearly a decade, Hammerand reported and edited business news for American City Business Journals as a reporter and digital editor at the Minneapolis/St. Paul Business Journal and then as managing editor of the Puget Sound Business Journal in Seattle. He holds degrees in journalism and management from the University of Minnesota and has won journalism awards from the Society of Professional Journalists, American Society of Business Publication Editors, and Trade, Association, Business Publications International. Connect with him on LinkedIn or by email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy